About tRNA-splicing ligase complex subunit FAM98B
tRNA-splicing ligase complex subunit FAM98B (FAM98B) is a protein
from Homo sapiens identified by UniProt accession
Q52LJ0, 433 residues long.
MolForge cross-references it against 0 known binders and
48 disease associations.
Target properties
| Protein name | tRNA-splicing ligase complex subunit FAM98B |
| UniProt accession | Q52LJ0 |
| Gene | FAM98B |
| Organism | Homo sapiens |
| Length | 433 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (48)
Diseases linked to this target (Open Targets).
- systemic lupus erythematosus · score 0.25
- mathematical ability · score 0.13
- bipolar disorder · score 0.13
- attention deficit hyperactivity disorder · score 0.12
- platelet count · score 0.12
- glomerular filtration rate · score 0.11
- platelet crit · score 0.10
- unipolar depression · score 0.10
- Tourette syndrome · score 0.10
- autism spectrum disorder · score 0.10
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q52LJ0-F1 | alphafold | PREDICTED | 72.59 | — |
Amino-acid sequence (433 residues)
MRGPEPGPQP TMEGDVLDTL EALGYKGPLL EEQALTKAAE GGLSSPEFSE LCIWLGSQIK SLCNLEESIT SAGRDDLESF QLEISGFLKE MACPYSVLIS GDIKDRLKKK EDCLKLLLFL STELQASQIL QNKKHKNSQL DKNSEVYQEV QAMFDTLGIP KSTTSDIPHM LNQVESKVKD ILSKVQKNHV GKPLLKMDLN SEQAEQLERI NDALSCEYEC RRRMLMKRLD VTVQSFGWSD RAKVKTDDIA RIYQPKRYAL SPKTTITMAH LLAAREDLSK IIRTSSGTSR EKTACAINKV LMGRVPDRGG RPNEIEPPPP EMPPWQKRQE GGGGRGGWGG GGGGGGRGGG GGGGGRGGWG GGGGGWGGGG GGGGGWGGGG GGGRGGFQGR GDYGGRGGYG GRGGYGGRGY GDPYGGGGGG GGGGGGGGGY RRY
Explore tRNA-splicing ligase complex subunit FAM98B with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets